Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R M Sharkey

Showing results (61-70 of 145) with videos related to

Pageof 15
Sort By:
International Journal of Cancer|December 15, 1989
Influence of animal host and tumor implantation site on radio-antibody uptake in the GW-39 human colonic cancer xenograftR D Blumenthal, R M Sharkey, R Kashi, et al.
International Journal of Cancer|May 28, 1992
The presence of a concomitant bulky tumor can decrease the uptake and therapeutic efficacy of radiolabeled antibodies in small tumorsO C Boerman, R M Sharkey, R D Blumenthal, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|January 1, 1997
Changes in tumor vascular permeability in response to experimental radioimmunotherapy: a comparative study of 11 xenograftsR D Blumenthal, R M Sharkey, R Kashi, et al.
Experimental Hematology|September 1, 1995
Improved experimental cancer therapy by radioantibody dose intensification as a result of syngeneic bone marrow transplantationR D Blumenthal, R M Sharkey, D Forman, et al.
Cancer Research|October 1, 1988
Reduction of radioantibody-induced myelotoxicity in hamsters by recombinant interleukin-1R D Blumenthal, R M Sharkey, D J Snyder, et al.
Cancer Research|August 15, 1991
Anthracycline immunoconjugates prepared by a site-specific linkage via an amino-dextran intermediate carrierL B Shih, D M Goldenberg, H Xuan, et al.
Cancer Research|June 1, 1988
Radioimmunotherapy of human colonic cancer xenografts with 90Y labeled monoclonal antibodies to carcinoembryonic antigenR M Sharkey, F A Kaltovich, L B Shih, et al.
American Journal of Obstetrics and Gynecology|June 1, 1977
The prognostic significance of carcinoembryonic antigen in the plasma and tumors of patients with endometrial adenocarcinomaJ R van Nagell, E S Donaldson, E G Wood, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|January 27, 1998
Pharmacokinetics, dosimetry and toxicity of rhenium-188-labeled anti-carcinoembryonic antigen monoclonal antibody, MN-14, in gastrointestinal cancerM Juweid, R M Sharkey, L C Swayne, et al.
Cancer Immunology, Immunotherapy : CII|January 1, 1991
The effect of antibody protein dose on the uniformity of tumor distribution of radioantibodies: an autoradiographic studyR D Blumenthal, I Fand, R M Sharkey, et al.
Pageof 15

Showing results (61-70 of 145) with videos related to

Sort By:
Pageof 15
International Journal of Cancer|December 15, 1989
Influence of animal host and tumor implantation site on radio-antibody uptake in the GW-39 human colonic cancer xenograftR D Blumenthal, R M Sharkey, R Kashi, et al.
International Journal of Cancer|May 28, 1992
The presence of a concomitant bulky tumor can decrease the uptake and therapeutic efficacy of radiolabeled antibodies in small tumorsO C Boerman, R M Sharkey, R D Blumenthal, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|January 1, 1997
Changes in tumor vascular permeability in response to experimental radioimmunotherapy: a comparative study of 11 xenograftsR D Blumenthal, R M Sharkey, R Kashi, et al.
Experimental Hematology|September 1, 1995
Improved experimental cancer therapy by radioantibody dose intensification as a result of syngeneic bone marrow transplantationR D Blumenthal, R M Sharkey, D Forman, et al.
Cancer Research|October 1, 1988
Reduction of radioantibody-induced myelotoxicity in hamsters by recombinant interleukin-1R D Blumenthal, R M Sharkey, D J Snyder, et al.
Cancer Research|August 15, 1991
Anthracycline immunoconjugates prepared by a site-specific linkage via an amino-dextran intermediate carrierL B Shih, D M Goldenberg, H Xuan, et al.
Cancer Research|June 1, 1988
Radioimmunotherapy of human colonic cancer xenografts with 90Y labeled monoclonal antibodies to carcinoembryonic antigenR M Sharkey, F A Kaltovich, L B Shih, et al.
American Journal of Obstetrics and Gynecology|June 1, 1977
The prognostic significance of carcinoembryonic antigen in the plasma and tumors of patients with endometrial adenocarcinomaJ R van Nagell, E S Donaldson, E G Wood, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|January 27, 1998
Pharmacokinetics, dosimetry and toxicity of rhenium-188-labeled anti-carcinoembryonic antigen monoclonal antibody, MN-14, in gastrointestinal cancerM Juweid, R M Sharkey, L C Swayne, et al.
Cancer Immunology, Immunotherapy : CII|January 1, 1991
The effect of antibody protein dose on the uniformity of tumor distribution of radioantibodies: an autoradiographic studyR D Blumenthal, I Fand, R M Sharkey, et al.
Pageof 15